[HTML][HTML] State of the art in the delivery of photosensitizers for photodynamic therapy
YN Konan, R Gurny, E Allémann - Journal of Photochemistry and …, 2002 - Elsevier
In photodynamic therapy, one of the problems limiting the use of many photosensitizers (PS)
is the difficulty in preparing pharmaceutical formulations that enable their parenteral …
is the difficulty in preparing pharmaceutical formulations that enable their parenteral …
Drug carrier for photodynamic cancer therapy
Photodynamic therapy (PDT) is a non-invasive combinatorial therapeutic modality using
light, photosensitizer (PS), and oxygen used for the treatment of cancer and other diseases …
light, photosensitizer (PS), and oxygen used for the treatment of cancer and other diseases …
[BOOK][B] Microencapsulation: methods and industrial applications
S Benita - 2005 - taylorfrancis.com
Presenting breakthrough research pertinent to scientists in a wide range of disciplines-from
medicine and biotechnology to cosmetics and pharmacy-this Second Edition provides …
medicine and biotechnology to cosmetics and pharmacy-this Second Edition provides …
Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery
K Avgoustakis - Current drug delivery, 2004 - ingentaconnect.com
The preparation, properties and potential applications in drug delivery of biocompatible and
biodegradable PLA-PEG and PLGA-PEG nanoparticles are discussed. PLA-PEG and PLGA …
biodegradable PLA-PEG and PLGA-PEG nanoparticles are discussed. PLA-PEG and PLGA …
Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer†,‡
MO Senge, JC Brandt - Photochemistry and photobiology, 2011 - Wiley Online Library
Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation
Photosensitizer†,‡ - Senge - 2011 - Photochemistry and Photobiology - Wiley Online Library …
Photosensitizer†,‡ - Senge - 2011 - Photochemistry and Photobiology - Wiley Online Library …
Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy
S Wang, R Gao, F Zhou, M Selke - Journal of Materials Chemistry, 2004 - pubs.rsc.org
In this review, we address a highly interdisciplinary field: the use of nanomaterials as
carriers for singlet oxygen photosensitizers and their potential applications in photodynamic …
carriers for singlet oxygen photosensitizers and their potential applications in photodynamic …
Nanotechnology on duty in medical applications
T Kubik, K Bogunia-Kubik… - Current pharmaceutical …, 2005 - ingentaconnect.com
At the beginning of 21st century, fifty years after discovery of deoxyribonucleic acid (DNA)
double helix structure, scientific world is faced with a great progress in many disciplines of …
double helix structure, scientific world is faced with a great progress in many disciplines of …
Colloidal drug carriers: achievements and perspectives
G Barratt - Cellular and Molecular Life Sciences CMLS, 2003 - Springer
Colloidal drug carriers such as liposomes and nanoparticles are able to modify the
distribution of an associated substance. They can therefore be used to improve the …
distribution of an associated substance. They can therefore be used to improve the …
Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density
VCF Mosqueira, P Legrand, JL Morgat, M Vert… - Pharmaceutical …, 2001 - Springer
Purpose: To study the pharmacokinetics and biodistribution of novel polyethyleneglycol
(PEG) surface-modified poly (rac-lactide)(PLA) nanocapsules (NCs) and to investigate the …
(PEG) surface-modified poly (rac-lactide)(PLA) nanocapsules (NCs) and to investigate the …
Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies
Enthusiasm for photodynamic therapy (PDT) as a promising technique to eradicate various
cancers has increased exponentially in recent decades. The majority of clinically approved …
cancers has increased exponentially in recent decades. The majority of clinically approved …